| For: | Makker J, Tariq H, Kumar K, Ravi M, Shaikh DH, Leung V, Hayat U, Hassan MT, Patel H, Nayudu S, Chilimuri S. Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study. World J Gastroenterol 2021; 27(6): 523-533 [PMID: 33642826 DOI: 10.3748/wjg.v27.i6.523] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i6/523.htm |
| Number | Citing Articles |
| 1 |
Masayuki Ueno, Haruhiko Takeda, Atsushi Takai, Hiroshi Seno. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives. World Journal of Gastroenterology 2022; 28(27): 3410-3421 doi: 10.3748/wjg.v28.i27.3410
|
| 2 |
Varun Damle, Akarshan Sharma, Brijendra Kumar Srivastava, Arkiath Veettil Raveendran, Krishna G. Seshadri, Viswanathan Mohan. Treatment Modalities for Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Review Article. Journal of Diabetology 2026; 17(2) doi: 10.4103/jod.jod_85_25
|
| 3 |
Nilay Danis, Sharon R. Weeks, Ahyoung Kim, Azarakhsh Baghdadi, Maryam Ghadimi, Ihab R. Kamel, Behnam Saberi, Tinsay Woreta, Jacqueline Garonzik‐Wang, Benjamin Philosophe, Ahmet Gurakar, Rohit Loomba. Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm. Liver Transplantation 2022; 28(4) doi: 10.1002/lt.26365
|
| 4 |
Elina En Li Cho, Chong Zhe Ang, Jingxuan Quek, Clarissa Elysia Fu, Lincoln Kai En Lim, Zane En Qi Heng, Darren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, Rebecca Zeng, Douglas Chee, Benjamin Nah, Cosmas Rinaldi Adithya Lesmana, Aung Hlaing Bwa, Khin Maung Win, Claire Faulkner, Majd B Aboona, Mei Chin Lim, Nicholas Syn, Anand V. Kulkarni, Hiroyuki Suzuki, Hirokazu Takahashi, Nobuharu Tamaki, Karn Wijarnpreecha, Daniel Q. Huang, Mark Muthiah, Cheng Han Ng, Rohit Loomba. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut 2023; 72(11) doi: 10.1136/gutjnl-2023-330110
|
| 5 |
Shunsuke Sato, Hidehiko Kawai, Masahiro Yamaguchi, Hiroki Nago, Yoko Kato, Rihwa Om, Yuichiro Terai, Yuji Kita, Yuji Ikeda, Sho Sato, Ayato Murata, Yuji Shimada, Takuya Genda. Fibrosis in Asymptomatic Steatotic Liver Disease With Normal Alanine Aminotransferase: Analysis of 2448 Health Check‐Up Cohort by Ultrasound Attenuation Imaging and Shear Wave Elastography. Journal of Gastroenterology and Hepatology 2025; 40(12) doi: 10.1111/jgh.70136
|
| 6 |
Md Nasir, Yixi Xu, Kyle Hasenstab, Alekhya Yechoor, Rahul Dodhia, William B. Weeks, Juan Lavista Ferres, Guilherme Moura Cunha, Wan-Long Chuang. Liver MRI proton density fat fraction inference from contrast enhanced CT images using deep learning: A proof-of-concept study. PLOS One 2025; 20(8) doi: 10.1371/journal.pone.0328867
|
| 7 |
Carlo Maria Alfieri, Paolo Molinari, Felice Cinque, Simone Vettoretti, Annalisa Cespiati, Daniela Bignamini, Luca Nardelli, Anna Ludovica Fracanzani, Giuseppe Castellano, Rosa Lombardi. What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives. International Journal of Molecular Sciences 2024; 25(14) doi: 10.3390/ijms25147728
|
| 8 |
José Raúl Herance, Queralt Martín-Saladich, Mayra Alejandra Velásquez, Cristina Hernandez, Carolina Aparicio, Clara Ramirez-Serra, Roser Ferrer, Marina Giralt-Arnaiz, Miguel Ángel González-Ballester, Juan M. Pericàs, Joan Castell-Conesa, Santiago Aguadé-Bruix, Rafael Simó. Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158783
|
| 9 |
Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Bogdan-Mircea Mihai. Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes. Biomedicines 2022; 10(10) doi: 10.3390/biomedicines10102375
|
| 10 |
Josh Bilson, Ryan M. Buchanan, Christopher D Byrne. Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes. Metabolism and Target Organ Damage 2026; 6(3) doi: 10.20517/mtod.2026.92
|
| 11 |
Seung Min Chung, Min Kyu Kang, Jun Sung Moon, Jung Gil Park. Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes. Endocrinology and Metabolism 2023; 38(2) doi: 10.3803/EnM.2022.1635
|
| 12 |
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 2024; 14(2) doi: 10.3390/life14020272
|